anticip preview number
move part made beat less like includ suppli mesh
paclitaxel issu report revenu in-lin surpris
segment result outsid weaker neuromod result anticip sinc
manag host investor day also strateg updat
except delay eu launch next-gen acur valv topic
cardiac procedur overal cardiovascular result in-lin
consensu enhanc comfort paclitaxel-rel concern may
reduc pre-op cardiac clearanc last quarter lessen continu
believ bode well cardiac-bas compani yet report turn
paclitaxel fda action dcb stent expect sometim august
manag commentari remain bullish continu use high-risk patient
though comparison found fda tone ambival overal
bsx quarterli updat expect still feel potenti
out-performance heighten enter second half compani
reiter full-year guidanc alreadi provid multi-year outlook
conserv assum modest contribut eluvia feel one
de-risk name coverag cash flow gener
nice cushion ep growth accret debt/leg oblig
subsid maintain buy rate pt
updat structur remain encourag detail us/eu
commerci launch lotu limit howev commentari legaci
busi notic upbeat acur valv see growth
europ next-gen acur devic improv pvl manag
anticip launch europ vs previous given chang
ce mark process compani streamlin submiss process
requir short-term invest import take-away
expect long-term drag overal turn watchman
manag confirm reimburs approv japan usd
better expect
tweak estim slightli trim revenu estim
modestli neuromod shortfal slightli weaker gross margin
quarter also reduc full-year forecast nudg
adj ep forecast penni
valuat maintain buy rate risk page
idc btig estim compani document
million except per share amount
rate buy view bsx broad product portfolio cardiovascular med-surg market
consist depend perform potenti upsid lotuss commerci ramp support posit
stabl procedur growth price
expans current tam
cut reimburs
one three
major player cardiac
make implant devic
use maintain normal
develop market product
sell product
structur heart
report consolid revenu tad forecast segment perform
cardiovascular endoscopi in-lin howev two standout mind weaker neuromod result
like last quarter better urolog sale neuromod manag note sale fell high-singl digit
 ou revenu manag highlight challeng grow top challeng comp
appear concern underli market growth
margin gross margin wors model though y/i improv due cost control reduc
scrap currenc adj sg margin fairli close compani continu activ streamlin initi
adj margin better net-net adj ebit margin forecast fairli
consist sequenti benefit lower tax rate vs adj ep came penni forecast
revenu trim neuromod estim shortfal tweak urolog forecast
better result model revenu growth unchang prior forecast
actualsbtig estimate varianceww sale cv sale endoscopi sale urology/gyn sale neuromod sale revenu oper incom net incom margin bpssg spend bpsr spend bpsadj ebit bpsadj tax rate bpssourc btig estim compani filingsvari
previous ep took tax rate trim ebit margin forecast flow
penni beat adjust ep estim increas previous
rate buy pt base month ep estim target multipl reflect
premium slower-grow large-cap peer par market-cap cap weight basket compani grow
revenu ep similarli view bsx divers product portfolio consist oper margin improv
potenti upsid recent support argument premium multipl risk includ soft emerg
market competit slippag product timelin chang procedur risk tavr reimburs futur
devic data fda use cash/m litig acquisit integr risk possibl multipl contract
exhibit comp tabl large-cap compani
oper net incom adj oper incom btig estim compani filingsnewold changentm johnsonjnjnot bdxnot scientificbuy factset data btig estimatespr ex-amortcompanytickerr ptpricemarket cap
boston scientif incom enet y/i product gross research adjust oper incom one-tim interest pre-tax provis incom tax adjust net adjust ep share net oper pre-tax net product product product product tax tax growth adjust adjust pre-tax pre-tax adjust incom tax adjust net adjust tax btig estim compani report
boston scientif revenu edrug-elut y/i y/i heart y/i y/i y/i y/i y/i y/i y/i y/i y/i pelvic y/i y/i btig estim compani report neuromodul reclassifi segment electrophysiolog form rhythm neuro segment begin
btig cover compani mention report
appendix analyst certif import disclosur
